Species differences in the metabolism and macromolecular binding of methapyrilene: a comparison of rat, mouse and hamster

References

• Brennan L. M., Creasia D. A. The effects of methapyrilene hydrochloride on hepatocarci-nogenecity and phenobarbital induced sleep time in rats and mice. Toxicology and Applied Pharmacology 1982; 66: 252–258
   PubMed Web of Science ®Google Scholar
• Casciano D. A., Shaddock J. G., Talska G. The potent hepatocarcinogen methapyrilene does not form DNA adducts in livers of Fischer 344 rats. Mutation Research 1988; 208: 129–135
   PubMed Web of Science ®Google Scholar
• Degan G. H., Neumann H. G. Differences in aflatoxin B1 susceptibility of rat and mouse are correlated with the capability in vitro to inactivate aflatoxin B1-epoxide. Carcinogenesis 1981; 2: 299–306
   PubMed Web of Science ®Google Scholar
• Fouts J. R., Brodie B. B. Inhibition of drug metabolic pathways by the potentiating agent 2,4-dichloro-6-phenyl-phenoxyethyldiethylamine. Journal of Pharmacology and Experimental Therapeutics 1955; 115: 68–72
   PubMed Web of Science ®Google Scholar
• Hernandez L., Lijinsky W. Glutathione and lipid peroxide levels in rat liver following administration of methapyrilene and analogs. Chemico-Biological Interactions 1989; 69: 217–224
   PubMed Web of Science ®Google Scholar
• Kammerer R. C., Froines J. R., Price T. Mutagenicity studies of selected antihistamines, their metabolites and products of nitrosation. Food and Chemical Toxicology 1986; 24: 981–985
   PubMed Web of Science ®Google Scholar
• Kammerer R. C., Kloc K. Synthesis of a deuterium labelled variant of the rat hepatocarcinogen methapyrilene. Journal of Labelled Compounds and Radiophharmaceuticals 1987; 24: 1469–1477
   Web of Science ®Google Scholar
• Kammerer R. C., Kloc K., Lampe M. A., Schmitz D. A. Oxidation of the pyridine ring: A major pathway of metabolism for the rat hepatocarcinogen, methapyrilene. Proceedings of the Western Pharmacology Society 1987; 30: 79–83
   PubMedGoogle Scholar
• Kammerer R. C., Lampe M. A. In vitro metabolism of chlorpheniramine in the rabbit. Biochemical Pharmacology 1987; 36: 3445–3452
   PubMed Web of Science ®Google Scholar
• Kammerer R. C., Schmitz D. A. Metabolism of methapyrilene by rat liver homogenate. Xenobiotica 1986; 16: 671–680
   PubMed Web of Science ®Google Scholar
• Kammerer R. C., Schmitz D. A. Species differences in the in vitro metabolism of methapyrilene. Xenobiotica 1987; 17: 1121–1130
   PubMed Web of Science ®Google Scholar
• Kammerer R. C., Schmitz D. A. A comparative in vitro metabolic study of methaphenilene and pyribenzamine. Xenobiotica 1988; 18: 1085–1096
   PubMed Web of Science ®Google Scholar
• Kammerer R. C., Schmitz D. A., Lampe M. A., Kloc K. The in vivo metabolism of methapyrilene, a hepatocarcinogen, in the rat. Xenobiotica 1988; 18: 869–881
   PubMed Web of Science ®Google Scholar
• Lampe M. A., Kammerer R. C. The effect of chronic methapyrilene treatment on methapyrilene metabolism in vitro. Carcinogenesis 1987a; 8: 221–226
   PubMed Web of Science ®Google Scholar
• Lampe M. A., Kammerer R. C. Cytochrome P-450 dependent binding of methapyrilene to DNA in vitro. Carcinogenesis 1987b; 8: 1525–1529
   PubMed Web of Science ®Google Scholar
• Lijinsky W., Knutsen G., Reuber M. D. Failure of methapyrilene to induce tumors in hamsters or guinea pigs. Journal of Toxicology and Environmental Health 1983; 12: 653–657
   PubMed Web of Science ®Google Scholar
• Lijinsky W., Reuber M. D., Blackwell B. N. Liver tumors induced by oral administration of the antihistamine methapyrilene hydrochloride. Science 1980; 209: 817–819
   PubMed Web of Science ®Google Scholar
• Lijinsky W., Yamashita K. Lack of binding of methapyrilene and similar antihistamines to rat liver DNA examined by 32P postlabeling. Cancer Research 1988; 48: 6475–6477
   PubMedGoogle Scholar
• Lotlikar P. D., Jhee E. C., Insetta S. M., Clearfield M. S. Modulation of microsome mediated aflatoxin B1 binding to exogenous and endogenous DNA by cytosolic glutathione-S-transferases in rat and hamster livers. Carcinogenesis 1984; 5: 269–276
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagant. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Lutz W. K. In vivo covalent binding of organic chemicals to DNA is a quantitative indicator in the process of chemical carcinogenesis. Mutation Research 1979; 65: 289–356
   PubMed Web of Science ®Google Scholar
• McQueen C. A., Williams G. M. Characterization of DNA repair elicited by carcinogens and drugs in hepatocyte primary culture/DNA repair test. Journal of Toxicology and Environmental Health 1981; 8: 463–477
   PubMed Web of Science ®Google Scholar
• Miller E. C., Miller J. A., Enomoto M. The comparative carcinogenecities of 2-acetylaminofluorene and its N-hydroxy metabolite in mice, hamsters and guinea pigs. Cancer Research 1964; 24: 2018–2030
   PubMed Web of Science ®Google Scholar
• Miller J. A., Miller E. C. The metabolic activation of carcinogenic aromatic amines and amides. Progress in Experimental Tumor Research 1969; 11: 273–301
   PubMed Web of Science ®Google Scholar
• Newberne P.M., Butler W. H. Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: a review. Cancer Research 1969; 29: 236–250
   PubMed Web of Science ®Google Scholar
• O'Brien K., Moss E., Judah D., Neal G. Metabolic basis of the species difference to aflatoxin B1 induced hepatotoxicity. Biochemical and Biophysical Research Communications 1983; 114: 813–821
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Probst G. S., Neal S. B. The induction of unscheduled DNA synthesis by antihistamines in primary hepatocyte cultures. Cancer Letters 1980; 10: 67–73
   PubMed Web of Science ®Google Scholar
• Raj H. G., Clearfield M. S., Lotlikar P. D. Comparative kinetic studies on aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation with rat and hamster livers in vitro. Carcinogenesis 1984; 5: 879–884
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Lalwai N. D. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Critical Reviews in Toxicology 1983; 12: 1–58
   Web of Science ®Google Scholar
• Singer B., Grunberger D. Metabolic activation of carcinogens and mutagens. Molecular Biology of Mutagens and Carcinogens. Plenum Press, New York 1984; 97–141
   Google Scholar
• Steinmetz K. L., Tyson C. K., Meierhenry E. F., Spaulding J. W., Mirsalis J. C. Examination of genotoxicity, toxicity and morphologic alterations in hepatocytes following in vivo or in vitro exposure to methapyrilene. Carcinogenesis 1988; 9: 959–963
   PubMed Web of Science ®Google Scholar
• Turner N. T., Wooley J. L., Hozier J. C., Sawyer J. R., Clive D. Methapyrilene is a genotoxic carcinogen: Studies on methapyrilene and pyrilamine in L5178Y/TK + /- mouse lymphoma assay. Mutation Research 1987; 189: 285–297
   PubMed Web of Science ®Google Scholar
• Ziegler D. M. Microsomal flavin-containing monooxygenases: Oxygenation of nucleophilic nitrogen and sulfur compounds. Enzymatic Basis of Detoxification, W. B. Jakoby. Academic Press, New York 1980; Vol. 1: 201–227
   Google Scholar